Andrew Lee Hong, M.D.
Affiliations: | 2014-2020 | Pediatric Oncology | Dana-Farber Cancer Institute, Boston, MA, United States |
2020- | Pediatric Oncology | Emory University, Atlanta, GA |
Area:
pediatric cancers, kidney cancers, functional genomicsGoogle:
"Andrew Hong"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mittal K, Cooper GW, Lee BP, et al. (2024) Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Communications Biology. 7: 426 |
Cooper GW, Hong AL. (2022) SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities. Cancers. 14 |
Su Y, Hong AL. (2022) Recent Advances in Renal Medullary Carcinoma. International Journal of Molecular Sciences. 23 |
Dai C, Rennhack JP, Arnoff TE, et al. (2021) SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization. Cell Reports. 36: 109443 |
Tan KT, Kim H, Carrot-Zhang J, et al. (2021) Haplotype-resolved germline and somatic alterations in renal medullary carcinomas. Genome Medicine. 13: 114 |
Neggers JE, Paolella BR, Asfaw A, et al. (2021) Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q. Cell Reports. 36: 109367 |
Dharia NV, Kugener G, Guenther LM, et al. (2021) A first-generation pediatric cancer dependency map. Nature Genetics |
Neggers JE, Paolella BR, Asfaw A, et al. (2020) Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q. Cell Reports. 33: 108493 |
Howard TP, Oberlick EM, Rees MG, et al. (2020) Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Durbin AD, Kugener G, Zimmerman MW, et al. (2020) Abstract B10: Rhabdomyosarcoma requires MYC family genomic events to pathogenically subvert core-regulatory circuitry Cancer Research. 80 |